ADEA's current member services platform is now offline for the transition to a new platform, launching later in November. Thank you for your patience as we improve your membership experience.


NDSS registration for people with steroid-induced diabetes resulting from COVID-19 treatment

People who have been treated for COVID-19 with high dose steroids (e.g. dexamethasone) and have subsequently developed steroid-induced diabetes can register with the NDSS with ‘other’ diabetes.

This will enable them to access a range of subsidised diabetes products and support through the NDSS.

To register people diagnosed with ‘other’ diabetes with the NDSS, please download and fill in the NDSS registration form.

The registration form can also be accessed through some clinical medical software.

For further information

For further information on National Diabetes Services Scheme (NDSS) registration for people with steroid-induced diabetes resulting from COVID-19 treatment, click here.

NDSS registration for people with steroid-induced diabetes resulting from COVID-19 treatment

People who have been treated for COVID-19 with high dose steroids (e.g. dexamethasone) and have subsequently developed steroid-induced diabetes can register with the NDSS with ‘other’ diabetes.

This will enable them to access a range of subsidised diabetes products and support through the NDSS.

To register people diagnosed with ‘other’ diabetes with the NDSS, please download and fill in the NDSS registration form.

The registration form can also be accessed through some clinical medical software.

For further information

For further information on National Diabetes Services Scheme (NDSS) registration for people with steroid-induced diabetes resulting from COVID-19 treatment, click here.